|
Delayed
Nasdaq Stockholm
18:06:27 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.750 SEK | +0.92% |
|
+0.57% | -11.17% |
| Market Cap | 258M 27.18M 23.29M 21.79M 19.92M 37.6M 2.6B 38M 100M 1.31B 102M 99.85M 4.32B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 258M 27.18M 23.29M 21.79M 19.92M 37.6M 2.6B 38M 100M 1.31B 102M 99.85M 4.32B | EV / Sales 2026 * |
2.53x | EV / Sales 2027 * | 1.82x |
| Free-Float |
86.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| 1 day | +0.92% | ||
| 1 week | +0.57% | ||
| Current month | +32.78% | ||
| 1 month | +40.45% | ||
| 3 months | +39.11% | ||
| 6 months | +10.20% | ||
| Current year | -11.17% |
| 1 week | 1.62 |  | 1.78 |
| 1 month | 1.23 | | 1.78 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.15 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 60 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
| Chairman | 68 | 20/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 01/07/26 | Buy | Chief Technology Officer | 4,016,742 | 5,035.0256% | ||
| 01/07/26 | Buy | Chief Executive Officer | 183,858 | 230.4678% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | +0.57% | -43.00% | -77.45% | 27.18M | |
| +0.83% | +2.06% | +79.90% | +125.94% | 1,111B | |
| +0.33% | +0.23% | +52.31% | +63.46% | 658B | |
| +0.22% | +2.14% | +27.42% | +80.28% | 467B | |
| +0.82% | +3.16% | +43.25% | +43.63% | 369B | |
| +0.90% | +1.59% | +26.00% | +42.18% | 301B | |
| +2.13% | +4.56% | +3.98% | +15.80% | 256B | |
| +0.11% | +4.13% | +53.52% | +72.74% | 240B | |
| +2.58% | +3.51% | -16.49% | -52.00% | 207B | |
| +0.75% | +2.09% | +28.29% | +90.53% | 182B | |
| Average | +0.94% | +4.39% | +25.52% | +40.51% | 379.1B | |
| Weighted average by Cap. | +0.78% | +4.68% | +46.27% | +72.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.75M 9.21M 8.62M 7.88M 14.87M 1.03B 15.03M 39.66M 517M 40.37M 39.5M 1.71B | 142M 14.95M 12.81M 11.98M 10.96M 20.67M 1.43B 20.89M 55.14M 719M 56.12M 54.91M 2.38B |
| Net income | -32.6M -3.44M -2.94M -2.75M -2.52M -4.75M -329M -4.8M -12.68M -165M -12.9M -12.62M -547M | 33.3M 3.51M 3.01M 2.81M 2.57M 4.86M 336M 4.91M 12.95M 169M 13.18M 12.89M 558M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | SEK 1.750 | +0.92% | 733,507 |
| 24/08/26 | SEK 1.734 | +0.93% | 673,345 |
| 21/08/26 | SEK 1.718 | +0.12% | 394,472 |
| 20/08/26 | SEK 1.716 | +1.42% | 491,885 |
| 19/08/26 | SEK 1.692 | -2.76% | 1,750,598 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
